Therefore, ASO-mediated modulation of cancer biomarkers, such as H2AFY protein expression, is one more tool that will help move research forward and contribute further insights into their roles and, possibly, provides new clinically relevant therapeutic targets. Here, MACROH2A1 is linked to cancer.